Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity of panitumumab in combination chemotherapy clinical trials.
Weeraratne D, Chen A, Pennucci JJ, Wu CY, Zhang K, Wright J, Pérez-Ruixo JJ, Yang BB, Kaliyaperumal A, Gupta S, Swanson SJ, Chirmule N, Starcevic M. Weeraratne D, et al. Among authors: kaliyaperumal a. BMC Clin Pharmacol. 2011 Nov 9;11:17. doi: 10.1186/1472-6904-11-17. BMC Clin Pharmacol. 2011. PMID: 22070868 Free PMC article. Clinical Trial.
A novel assay to measure B cell responses to keyhole limpet haemocyanin vaccination in healthy volunteers and subjects with systemic lupus erythematosus.
Ferbas J, Belouski SS, Horner M, Kaliyaperumal A, Chen L, Boyce M, Colaço CB, McHugh N, Quick V, Nicholl RJ, Siu G, Chung J. Ferbas J, et al. Among authors: kaliyaperumal a. Br J Clin Pharmacol. 2013 Aug;76(2):188-202. doi: 10.1111/bcp.12172. Br J Clin Pharmacol. 2013. PMID: 23731388 Free PMC article. Review.
A Proposal to Redefine Clinical Immunogenicity Assessment.
Mytych DT, Hock MB, Kroenke M, Jawa V, Kaliyaperumal A, Zhou Y. Mytych DT, et al. Among authors: kaliyaperumal a. AAPS J. 2017 May;19(3):599-602. doi: 10.1208/s12248-017-0059-7. Epub 2017 Feb 28. AAPS J. 2017. PMID: 28247192
Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials.
Stohl W, Merrill JT, Looney RJ, Buyon J, Wallace DJ, Weisman MH, Ginzler EM, Cooke B, Holloway D, Kaliyaperumal A, Kuchimanchi KR, Cheah TC, Rasmussen E, Ferbas J, Belouski SS, Tsuji W, Zack DJ. Stohl W, et al. Among authors: kaliyaperumal a. Arthritis Res Ther. 2015 Aug 20;17(1):215. doi: 10.1186/s13075-015-0741-z. Arthritis Res Ther. 2015. PMID: 26290435 Free PMC article. Clinical Trial.
T cells of lupus and molecular targets for immunotherapy.
Datta SK, Kaliyaperumal A, Desai-Mehta A. Datta SK, et al. Among authors: kaliyaperumal a. J Clin Immunol. 1997 Jan;17(1):11-20. doi: 10.1023/a:1027328226918. J Clin Immunol. 1997. PMID: 9049781 Review.
102 results